Open AccessPossible reasons for the inefficacy of genetically engineered biological agents in rheumatoid arthritis and ways of its prevention
Author(s) -
Н. В. Чичасова
Publication year - 2012
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2012-725
Subject(s) - rheumatoid arthritis , medicine , methotrexate , disease , genetically engineered , tumor necrosis factor alpha , arthritis , biological response modifiers , intensive care medicine , immunology , immune system , gene , biochemistry , chemistry